Thomas F. Woiwode's most recent trade in Passage Bio Inc was a trade of 24,000 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 25, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Passage Bio Inc | Thomas F. Woiwode | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 24,000 | 24,000 | - | - | Director Stock Option (Right to Buy) |